EC Number   |
Title |
Organism |
|---|
    1.14.19.17 | Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity |
Chlorocebus aethiops |
| 1.14.19.17 | Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity |
Mus musculus |
| 1.14.19.17 | Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity |
Homo sapiens |
| 1.14.19.17 | Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity |
Drosophila melanogaster |
| 1.14.19.17 | Dihydroceramide desaturase inhibitors induce autophagy via dihydroceramide-dependent and independent mechanisms |
Homo sapiens |
| 1.14.19.17 | Dihydroceramide-desaturase-1-mediated caspase 9 activation through ceramide plays a pivotal role in palmitic acid-induced HepG2 cell apoptosis |
Homo sapiens |
| 1.14.19.17 | From sphingosine kinase to dihydroceramide desaturase a structure-activity relationship (SAR) study of the enzyme inhibitory and anticancer activity of 4-((4-(4-chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II) |
Homo sapiens |
| 1.14.19.17 | From the configurational preference of dihydroceramide desaturase-1 towards DELTA6-unsaturated substrates to the discovery of a new inhibitor |
Homo sapiens |
| 1.14.19.17 | Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment |
Homo sapiens |
| 1.14.19.17 | Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II |
Homo sapiens |
